Leonid Timashev
Stock Analyst at RBC Capital
(4.51)
# 249
Out of 5,067 analysts
131
Total ratings
57.76%
Success rate
18.46%
Average return
Main Sectors:
Stocks Rated by Leonid Timashev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DSGN Design Therapeutics | Upgrades: Outperform | $6 → $13 | $8.64 | +50.46% | 10 | Nov 20, 2025 | |
| ONC BeOne Medicines AG | Maintains: Outperform | $395 → $408 | $332.71 | +22.63% | 5 | Nov 18, 2025 | |
| CGON CG Oncology | Maintains: Outperform | $53 → $61 | $43.56 | +40.04% | 2 | Nov 17, 2025 | |
| LEGN Legend Biotech | Maintains: Outperform | $75 → $74 | $27.15 | +172.56% | 14 | Nov 13, 2025 | |
| JSPR Jasper Therapeutics | Maintains: Sector Perform | $5 → $4 | $1.72 | +132.56% | 1 | Nov 11, 2025 | |
| CYTK Cytokinetics | Maintains: Outperform | $82 → $87 | $67.21 | +29.45% | 4 | Nov 11, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Outperform | $49 → $50 | $23.48 | +112.95% | 15 | Nov 7, 2025 | |
| XNCR Xencor | Maintains: Outperform | $18 → $19 | $16.74 | +13.50% | 3 | Nov 6, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Outperform | $39 → $44 | $39.31 | +11.93% | 8 | Nov 6, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Outperform | $151 → $155 | $180.90 | -14.32% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $19 → $9 | $9.68 | -7.02% | 13 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $8 | $7.41 | +7.96% | 3 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $189 → $198 | $151.20 | +30.95% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $77 | $73.66 | +4.53% | 1 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $139 → $215 | $206.93 | +3.90% | 6 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $27 → $11 | $6.74 | +63.20% | 2 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $47 | $28.20 | +66.67% | 5 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $45 | $42.25 | +6.51% | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $21 → $22 | $9.82 | +124.03% | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $38 → $41 | $34.66 | +18.29% | 3 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $13 | $9.84 | +32.11% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $5 | $4.37 | +14.42% | 1 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $16 | $2.17 | +637.33% | 1 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $8 | $5.15 | +55.34% | 6 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.19 | +152.10% | 1 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $70 | $106.24 | -34.11% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $18 | $5.18 | +247.49% | 4 | Jan 15, 2025 |
Design Therapeutics
Nov 20, 2025
Upgrades: Outperform
Price Target: $6 → $13
Current: $8.64
Upside: +50.46%
BeOne Medicines AG
Nov 18, 2025
Maintains: Outperform
Price Target: $395 → $408
Current: $332.71
Upside: +22.63%
CG Oncology
Nov 17, 2025
Maintains: Outperform
Price Target: $53 → $61
Current: $43.56
Upside: +40.04%
Legend Biotech
Nov 13, 2025
Maintains: Outperform
Price Target: $75 → $74
Current: $27.15
Upside: +172.56%
Jasper Therapeutics
Nov 11, 2025
Maintains: Sector Perform
Price Target: $5 → $4
Current: $1.72
Upside: +132.56%
Cytokinetics
Nov 11, 2025
Maintains: Outperform
Price Target: $82 → $87
Current: $67.21
Upside: +29.45%
Edgewise Therapeutics
Nov 7, 2025
Maintains: Outperform
Price Target: $49 → $50
Current: $23.48
Upside: +112.95%
Xencor
Nov 6, 2025
Maintains: Outperform
Price Target: $18 → $19
Current: $16.74
Upside: +13.50%
NewAmsterdam Pharma Company
Nov 6, 2025
Maintains: Outperform
Price Target: $39 → $44
Current: $39.31
Upside: +11.93%
Jazz Pharmaceuticals
Nov 6, 2025
Maintains: Outperform
Price Target: $151 → $155
Current: $180.90
Upside: -14.32%
Nov 6, 2025
Maintains: Sector Perform
Price Target: $19 → $9
Current: $9.68
Upside: -7.02%
Nov 4, 2025
Maintains: Outperform
Price Target: $7 → $8
Current: $7.41
Upside: +7.96%
Nov 4, 2025
Maintains: Outperform
Price Target: $189 → $198
Current: $151.20
Upside: +30.95%
Nov 3, 2025
Initiates: Outperform
Price Target: $77
Current: $73.66
Upside: +4.53%
Oct 31, 2025
Maintains: Outperform
Price Target: $139 → $215
Current: $206.93
Upside: +3.90%
Oct 31, 2025
Downgrades: Sector Perform
Price Target: $27 → $11
Current: $6.74
Upside: +63.20%
Oct 23, 2025
Maintains: Outperform
Price Target: $45 → $47
Current: $28.20
Upside: +66.67%
Oct 21, 2025
Reiterates: Sector Perform
Price Target: $45
Current: $42.25
Upside: +6.51%
Oct 21, 2025
Maintains: Outperform
Price Target: $21 → $22
Current: $9.82
Upside: +124.03%
Oct 21, 2025
Maintains: Outperform
Price Target: $38 → $41
Current: $34.66
Upside: +18.29%
Aug 8, 2025
Maintains: Outperform
Price Target: $12 → $13
Current: $9.84
Upside: +32.11%
Jun 20, 2025
Maintains: Outperform
Price Target: $8 → $5
Current: $4.37
Upside: +14.42%
Jun 3, 2025
Maintains: Outperform
Price Target: $15 → $16
Current: $2.17
Upside: +637.33%
Mar 19, 2025
Reiterates: Outperform
Price Target: $8
Current: $5.15
Upside: +55.34%
Mar 19, 2025
Maintains: Buy
Price Target: $3
Current: $1.19
Upside: +152.10%
Jan 23, 2025
Reiterates: Sector Perform
Price Target: $70
Current: $106.24
Upside: -34.11%
Jan 15, 2025
Reiterates: Outperform
Price Target: $18
Current: $5.18
Upside: +247.49%